Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-128208
Filing Date
2024-11-18
Accepted
2024-11-18 21:12:24
Documents
1
Period of Report
2024-11-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9016
  Complete submission text file 0000950170-24-128208.txt   11139
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 241473139

Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Issuer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ARA HILL TOP BUILDING, UNIT A-5 PLETTERIJWEG OOST 1, CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH TARGET N V (Reporting) CIK: 0001259870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 241473140